GlassScriptPhysician profile
Alan E Szczesniewski
NPI 1750313573
$1,065.62
in general payments reported to CMS, 2019-2025
18 companies · $211 in 2025
The $211 reported for 2025 was less than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $89.54 · 2020: $78.62 · 2021: $109 · 2022: $247 · 2023: $172 · 2024: $159 · 2025: $211.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $542.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $541.93 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sun Pharmaceutical Industries INC. | $283.15 | 2019-2025 | Cequa |
| Bausch & Lomb Americas INC. | $146.03 | 2022-2025 | Miebo, Xiidra, Vyzulta |
| Tarsus Pharmaceuticals, INC. | $106.77 | 2024-2025 | Xdemvy |
| Biotissue Holdings INC. | $64.80 | 2019-2024 | |
| Alcon Vision LLC | $59.71 | 2021-2025 | Tryptyr |
| Allergan, INC. | $58.85 | 2020-2021 | |
| Oyster Point Pharma, INC. | $56.33 | 2022-2023 | Tyrvaya |
| Johnson & Johnson Vision Care, INC. | $40.13 | 2022 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $39.99 | 2019-2021 | |
| Abbvie INC. | $38.38 | 2022 | |
| Kala Pharmaceuticals, INC. | $32.42 | 2019-2021 | |
| Dompe US, INC. | $30.74 | 2022 | |
| Johnson & Johnson Surgical Vision, INC. | $25.82 | 2020-2023 | Tecnis Iol |
| Aerie Pharmaceuticals, INC. | $22.48 | 2019 | |
| Novartis Pharmaceuticals Corporation | $17.90 | 2022 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Thea Pharma INC. | $16.76 | 2023 | |
| Sight Sciences, INC. | $15.69 | 2021 | |
| Abb Con-Cise Optical Group LLC | $9.67 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alan Szczesniewski listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.